Product Information
CARBIDOPA-LEVODOPA 25-250 TAB is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.1112 per EA under NDC 50228045905. Its NADAC has been published 252 times since Sep 1, 2021.
Strength
25; 250 mg/1; mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228045905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214092On Market Since
5/7/2021
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has been published 252 times since Sep 1, 2021, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1112 per EA |
|---|---|
| All-time high | $0.1761 (Oct 13, 2021) |
| All-time low | $0.0731 (Apr 17, 2024) |
| 52-week high | $0.1403 |
| 52-week low | $0.1104 |
| Median price | $0.1386 |
| Average price | $0.1357 |
| Largest weekly change | +71.8% (Jun 19, 2024) |
| Weeks tracked | 252 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-250 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-250 TAB, manufactured by ScieGen Pharmaceuticals Inc., is $0.1112 per EA (NDC 50228045905), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-250 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has declined 33.9%. It has been tracked across 252 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-250 TAB?
Since Sep 1, 2021, the NADAC for CARBIDOPA-LEVODOPA 25-250 TAB has ranged from a low of $0.0731 (Apr 17, 2024) to a high of $0.1761 (Oct 13, 2021), with a median of $0.1386 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-250 TAB?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 25-250 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-250 TAB?
CARBIDOPA-LEVODOPA 25-250 TAB (NDC 50228045905) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification